rs149145821
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001283009.2(RTEL1):c.3463G>A(p.Val1155Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000918 in 1,612,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.3463G>A | p.Val1155Met | missense_variant | 33/35 | ENST00000360203.11 | NP_001269938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.3463G>A | p.Val1155Met | missense_variant | 33/35 | 5 | NM_001283009.2 | ENSP00000353332.5 | ||
RTEL1 | ENST00000508582.7 | c.3535G>A | p.Val1179Met | missense_variant | 33/35 | 2 | ENSP00000424307.2 | |||
RTEL1 | ENST00000370018.7 | c.3463G>A | p.Val1155Met | missense_variant | 33/35 | 1 | ENSP00000359035.3 | |||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.*1065G>A | non_coding_transcript_exon_variant | 30/35 | 5 | ENSP00000457428.1 | ||||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.*1065G>A | 3_prime_UTR_variant | 30/35 | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152038Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 34AN: 245236Hom.: 0 AF XY: 0.000150 AC XY: 20AN XY: 133682
GnomAD4 exome AF: 0.0000829 AC: 121AN: 1459940Hom.: 0 Cov.: 35 AF XY: 0.0000936 AC XY: 68AN XY: 726280
GnomAD4 genome AF: 0.000177 AC: 27AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74376
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal recessive 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 09, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2022 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1155 of the RTEL1 protein (p.Val1155Met). This variant is present in population databases (rs149145821, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with RTEL1-related conditions. This variant is also known as c.3535G>A (p.Val1179Met). ClinVar contains an entry for this variant (Variation ID: 582053). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at